Close X
Thursday, December 26, 2024
ADVT 
International

Trudeau commits $25M in aid for Palestinians

Darpan News Desk The Canadian Press, 28 May, 2021 03:27 PM
  • Trudeau commits $25M in aid for Palestinians

Canada will provide $25 million to Palestinian civilians affected by the recent conflict between the Israelis and the Palestinians in Gaza Strip and the West Bank, Prime Minister Justin Trudeau said Friday.

Trudeau said in a news release the funding will go directly to experienced organizations which will help the most vulnerable Palestinian civilians cope with the impacts of the recent conflict.

"The recent violence in the region is alarming — we have all seen the disturbing images of displaced civilians, loss of life, and pain inflicted on families," Trudeau said.

Canada's aid will include $10 million for urgent food assistance, shelter, water, sanitation and hygiene and psychosocial support for children and $10 million to support humanitarian and rebuilding efforts, such as vital medical infrastructure.

Trudeau said Canada will also dedicate up to $5 million for peace-building initiatives that advance the goal of a comprehensive, just and lasting peace between the Palestinians and the Israelis.

International Development Minister Karina Gould said the aid will provide timely humanitarian assistance and support people in Gaza to recover from the damage caused by the recent conflict.

Last week, Canada welcomed a ceasefire ending the 11-day war between Israel and Hamas that left hundreds of people dead.

At least 230 Palestinians were killed, including 65 children and 39 women, with 1,710 people wounded, according to the Gaza Health Ministry. Twelve people in Israel were killed.

Before the recent conflict, the United Nations estimated that approximately 1.57 million people in Gaza, out of a total population of 2 million, were in need of humanitarian assistance.

In December, Canada committed funding of $90 million over three years to respond to the rising needs of vulnerable Palestinian refugees.

This report was first published by The Canadian Press on May 28, 2021.

—-

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19